In a patient with ulcerative colitis and a nodule in the pouch of Douglas with a negative pelvic exam for malignancy, which test should be performed first: colonoscopy or PET‑CT?

Perform Colonoscopy First

In a patient with ulcerative colitis and a pouch of Douglas nodule with negative pelvic exam for malignancy, colonoscopy should be performed first. The UC surveillance needs are time-sensitive and guideline-mandated, while the nodule can be characterized through a stepwise approach that may not require PET-CT at all.

Rationale for Prioritizing Colonoscopy

UC Surveillance is Non-Negotiable

Patients with UC require systematic surveillance colonoscopy to detect dysplasia and colorectal cancer, which carries significantly increased risk compared to the general population 1. Screening colonoscopy should be offered within 8 years following symptom onset to reassess disease extent and exclude dysplasia 1. If this patient is due for surveillance, delaying it for a nodule workup that may prove benign is inappropriate prioritization.

The surveillance colonoscopy serves multiple critical functions 1:

• Reassesses true microscopic disease extent (endoscopic appearance underestimates extent in quiescent UC)
• Detects dysplasia before progression to cancer
• Establishes baseline for future surveillance intervals
• Should be performed when UC is in remission for optimal dysplasia detection

The Nodule Requires Stepwise Evaluation, Not Immediate PET-CT

A pouch of Douglas nodule with negative pelvic exam for malignancy suggests lower pre-test probability of cancer. The appropriate workup sequence is:

1. First-line imaging: Pelvic MRI or CT 2

   • Cross-sectional imaging (MRI preferred, CT acceptable) is recommended for pelvic pathology evaluation in IBD patients
   • Can characterize the nodule's size, characteristics, and relationship to surrounding structures
   • MRI provides superior soft tissue resolution without radiation

2. PET-CT is reserved for specific indications:

   • When cross-sectional imaging is indeterminate
   • When malignancy is strongly suspected and staging is needed
   • Not a first-line diagnostic tool for incidental pelvic nodules

Clinical Context Matters

If the patient has longstanding extensive UC (>8 years), colonoscopy becomes even more urgent 3, 1. The risk of colorectal cancer increases with disease duration and extent, with surveillance potentially permitting earlier cancer detection and improved prognosis 1.

For patients with primary sclerosing cholangitis (PSC) concurrent with UC, annual surveillance colonoscopy is mandatory regardless of disease activity 1, making any delay for nodule workup particularly problematic.

Practical Algorithm

Proceed with colonoscopy first if:

• Patient is due for UC surveillance (≥8 years from symptom onset, or per established surveillance schedule)
• UC is in remission (optimal timing for surveillance) 1
• Patient has high-risk features (PSC, family history of CRC, extensive colitis)

After colonoscopy, address the nodule:

1. Order pelvic MRI (preferred) or CT as initial imaging 2
2. If imaging shows benign features → clinical follow-up
3. If imaging is indeterminate or suspicious → consider PET-CT for further characterization
4. If clearly malignant on MRI/CT → proceed directly to appropriate oncologic workup

Common Pitfalls to Avoid

• Don't delay UC surveillance for incidental findings with low malignancy probability. The negative pelvic exam significantly reduces pre-test probability of cancer in the nodule.

• Don't order PET-CT as first-line imaging for pelvic nodules. While emerging evidence suggests FAPI-PET may have utility in IBD assessment 4, 5, this is investigational and not standard practice. PET-CT for nodule characterization should follow, not precede, anatomic imaging.

• Don't perform colonoscopy during active UC flare if possible 1. If UC is currently active, optimize medical therapy first, then perform surveillance when in remission for better dysplasia detection.

• Ensure adequate bowel preparation 1. Poor preparation significantly affects lesion detection rates and may necessitate repeat examination.

The colonoscopy addresses a known, guideline-mandated cancer risk, while the nodule workup can proceed systematically without compromising outcomes. This prioritization optimizes both morbidity and mortality outcomes for this patient.